ArticleClinical drug investigation2010

Safety and tolerability of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis: data from six clinical and phase I safety studies.

Timothy L Comstock et al.PubMed ↗Publisher ↗

No numbers read from the abstract.